Commentary Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.46439/pathology.3.011
Cancer of unknown primary site (CUP), practice-changing diagnosis and therapy in the molecular era: a commentary
Jeffery Russell1, F. Anthony Greco1,*
- 1Tennessee Oncology, Greco-Hainsworth Centers for Research, Nashville, Tennessee, USA
Corresponding Author
F. Anthony Greco; fgreco@tnonc.com
Received Date: November 25, 2025
Accepted Date: February 18, 2026
Russell J, Greco FA. Cancer of unknown primary site (CUP), practice-changing diagnosis and therapy in the molecular era: a commentary. J Exp Mol Pathol. 2026;3(1):4-7.
Copyright: © 2026 Russell J, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
Cancer, next generation sequencing, chemotherapy, carcinoma, Epstein-Bar virus
Recommended Articles
Neodymium:YAG laser posterior capsulotomy in the lateral decubitus position
Here we report a novel method of performing a Neodyminium:YAG (Nd:YAG) laser posterior capsulotomy in an adult patient, unable to tolerate the procedure awake with topical anaesthesia in the outpatient clinic setting. The procedure was performed by altering the chin rest and arms of the Nd:YAG laser machine so that the procedure could be undertaken in an anaesthetized patient in the operating theatre, in the lateral decubitus position, with the laser machine upright in its normal position.
Presbyopia correcting IOLs and the ocular surface disease… The good, the bad and the ugly
The last two decades were especially fruitful for the refractive surgeons and for the industry who have been showing tremendous development in both understanding and meeting patients’ desire for spectacle independence. Ever since the first trials from Dr. Kenneth Hoffer with his early 1980’s effort in producing a multifocal IOL to the latest achievements from different companies in putting trifocals and EDOF optics to the market.
How many mutations does it take to make a uveal melanoma?
Uveal melanoma (UM) is a rare cancer that affects the choroid and, less frequently, the ciliary body or the iris (for recent reviews see [1-3]). Despite a profound knowledge of the oncogenic mechanisms behind UM tumorigenesis and despite an accurate cytogenetic and molecular prognosis, only limited advances have been made in UM therapy.
MSICS is a Simple Solution for a Big Problem
Manual small-incision cataract surgery (MSICS) is a sutureless cataract surgery that has multiple advantages over traditional phacoemulsification and extracapsular cataract extraction (ECCE) procedures. SICS became the procedure of choice for international ophthalmology, where the microscopes and operating room can be more challenging, in addition to the more advanced pathology often seen.
Surgical smoke and SARS-CoV-2 transmission
The protection of health care workers from nosocomial infection is a paramount consideration in the current pandemic involving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Not only is prevention of viral transmission the most effective means to lessen the public health impact of coronavirus disease 2019 (COVID-19), but also both quarantine and illness – that disproportionately affect health care workers – have devastating effects on the ability of hospitals to adequately care for increased patient loads.